Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial.
Lancet. 2023 May 6;401(10387):1518-1529. doi: 10.1016/S0140-6736(23)00222-2. Epub 2023 Apr 14.
Lancet. 2023.
PMID: 37062298
Clinical Trial.
A plain language summary on ritlecitinib treatment for adults and adolescents with alopecia areata.
King B, Zhang X, Harcha WG, Szepietowski JC, Shapiro J, Lynde C, Mesinkovska NA, Zwillich SH, Napatalung L, Wajsbrot D, Fayyad R, Freyman A, Mitra D, Purohit V, Sinclair R, Wolk R.
King B, et al. Among authors: freyman a.
Immunotherapy. 2023 Oct;15(14):1093-1103. doi: 10.2217/imt-2023-0069. Epub 2023 Jul 5.
Immunotherapy. 2023.
PMID: 37403610
Free article.
Review.
Item in Clipboard
Phase I/II study to assess the clinical pharmacology and safety of single ascending and multiple subcutaneous doses of PF-06881894 in women with non-distantly metastatic breast cancer.
Yao HM, Jones SR, Morales S, Moosavi S, Zhang J, Freyman A, Ottery FD.
Yao HM, et al. Among authors: freyman a.
Cancer Chemother Pharmacol. 2021 Dec;88(6):1033-1048. doi: 10.1007/s00280-021-04355-6. Epub 2021 Oct 7.
Cancer Chemother Pharmacol. 2021.
PMID: 34618197
Free PMC article.
Clinical Trial.
Item in Clipboard
PF-05280014 (a trastuzumab biosimilar) plus paclitaxel compared with reference trastuzumab plus paclitaxel for HER2-positive metastatic breast cancer: a randomised, double-blind study.
Pegram MD, Bondarenko I, Zorzetto MMC, Hingmire S, Iwase H, Krivorotko PV, Lee KS, Li RK, Pikiel J, Aggarwal R, Ewesuedo R, Freyman A, Li R, Vana A, Yin D, Zacharchuk C, Tan-Chiu E.
Pegram MD, et al. Among authors: freyman a.
Br J Cancer. 2019 Jan;120(2):172-182. doi: 10.1038/s41416-018-0340-2. Epub 2018 Dec 20.
Br J Cancer. 2019.
PMID: 30568294
Free PMC article.
Clinical Trial.
Item in Clipboard
Evaluating imbalances of adverse events during biosimilar development.
Vana AM, Freyman AW, Reich SD, Yin D, Li R, Anderson S, Jacobs IA, Zacharchuk CM, Ewesuedo R.
Vana AM, et al. Among authors: freyman aw.
MAbs. 2016 Jul;8(5):861-6. doi: 10.1080/19420862.2016.1171431. Epub 2016 Apr 6.
MAbs. 2016.
PMID: 27050730
Free PMC article.
Item in Clipboard
Combination neratinib (HKI-272) and paclitaxel therapy in patients with HER2-positive metastatic breast cancer.
Chow LW, Xu B, Gupta S, Freyman A, Zhao Y, Abbas R, Vo Van ML, Bondarenko I.
Chow LW, et al. Among authors: freyman a.
Br J Cancer. 2013 May 28;108(10):1985-93. doi: 10.1038/bjc.2013.178. Epub 2013 Apr 30.
Br J Cancer. 2013.
PMID: 23632474
Free PMC article.
Clinical Trial.
Item in Clipboard
Neratinib, an irreversible pan-ErbB receptor tyrosine kinase inhibitor: results of a phase II trial in patients with advanced non-small-cell lung cancer.
Sequist LV, Besse B, Lynch TJ, Miller VA, Wong KK, Gitlitz B, Eaton K, Zacharchuk C, Freyman A, Powell C, Ananthakrishnan R, Quinn S, Soria JC.
Sequist LV, et al. Among authors: freyman a.
J Clin Oncol. 2010 Jun 20;28(18):3076-83. doi: 10.1200/JCO.2009.27.9414. Epub 2010 May 17.
J Clin Oncol. 2010.
PMID: 20479403
Clinical Trial.
Item in Clipboard
Cite
Cite